Central nervous system infections in children caused by group A Streptococcus are rare. This study, conducted across 52 hospitals in Spain from 2019 to 2023, identified 32 cases of central nervous system infections in children caused by group A Streptococcus, with a significant increase from October 2022 onward (1.1% vs. 5.9%, P = 0.002). Half required pediatric intensive care unit admission, 12.5% exhibited sequelae and the mortality rate was 6.2%. Mastoiditis was the predominant primary infection.
Background: One of the main drawbacks of tunneled central venous catheters (CVCs) is catheter-related bloodstream infections (CRBSIs). Antibiotic lock therapy (ALT) can be combined with systemic antibiotics to achieve catheter salvage. Our objectives are to describe cases of CRBSI and our experience with ALT in a pediatric oncology–hematology ward. Methods: a retrospective descriptive study of pediatric CRBSI cases in a Spanish oncology–hematology unit from 2007 to 2017 was conducted. We collected demographic, clinical, and microbiological data from all patients. Results: fifty-eight CRBSIs were diagnosed in thirty-nine patients; 72.9% of these patients were male, with a median age of 42.1 months. The main underlying diseases were leukemia/lymphoma (51.7%) and solid tumors (32.7%). Thirty-five (60.3%) CRBSIs were caused by Gram-positive cocci, of which 70.6% were coagulase-negative Staphylococci, and sixteen (27.6%) were caused by Gram-negative bacilli. We treated 41/58 (71%) cases with ALT. A total of 12/17 (71%) CVCs that were not treated with adjunctive ALT were removed, compared with 13/41 (32%) that were treated with ALT (relative risk (RR), 0.449; confidence interval (CI), 95%: 0.259–0.778, p = 0.004). Major reasons to remove the CVC in the CRBSI-ALT group were local insertion/pocket site infection (23%), persistent symptoms (23%), and infectious’ relapses (15%). Conclusions: ALT was shown to be an effective approach to keeping the CVC in place, with no added adverse effects.
18 August 2026 in The Pediatric Infectious Disease Journal
Background: Streptococcus pyogenes (group A Streptococcus , GAS) is a common pediatric pathogen causing a wide range of diseases with significant morbidity and mortality. GAS infections exhibit strong seasonal patterns, and the invasive forms (iGAS) have historically been associated with influenza. Since September 2022, a global outbreak of both iGAS and noninvasive GAS infections has been reported. Methods: This is a retrospective observational multicentric study of children (<15 years) with iGAS in Catalonia (Spain) from week 40 of 2022 to week 24 of 2023. We collected clinical, epidemiologic and microbiologic data on iGAS, scarlet fever and acute respiratory infection diagnoses between 2013 and the study period. Seasonal comparisons were assessed using Kruskal–Wallis and Wilcoxon tests, and correlations between weekly time series were evaluated using Spearman coefficients. Results: Among 135 pediatric iGAS cases, the median age was 3.7 years (interquartile range, 1.6–5.9), mostly healthy. Fever was the most common symptom (92.6%), and pneumonia was the most prevalent diagnosis (40.7%). Viral coinfection occurred in 59.3% of the cases, with influenza A/B being the most prevalent. One-third (35.6%) required intensive care; the case fatality rate was 3.0%. We found a significant correlation between pediatric iGAS infections and influenza A/B circulation (ρ = 0.85) in the context of significantly higher scarlet fever incidence compared with pandemic and pre-pandemic seasons. Weaker correlations were identified between iGAS infections and the other acute viral infections studied. Conclusions: Pediatric iGAS during the 2022–2023 outbreak was strongly associated with influenza activity, suggesting that influenza might contribute to the epidemiology of pediatric iGAS in a context of increased GAS circulation.
Purpose: Studies have shown increased invasive Group A Streptococcus (GAS) disease, including bloodstream infections (GAS-BSI). However, the epidemiological data of GAS-BSI are limited in children. We aimed to describe GAS-BSI in Spanish children over 13 years (2005-2017). Methods: Multicenter retrospective cohort study from 16 Spanish hospitals. Epidemiology, symptomatology, laboratory, treatment, and outcome of GAS-BSI in children ≤16 years were analyzed. Results: 109 cases of GAS-SBI were included, with incidence rate of 4.3 episodes/100,000 children attended at the emergency department/year. We compared incidence between two periods (P1:2005-June 2011 vs P2:July 2011-2017) and observed a non-significant increase along the study period (APC:+6.0% [95%CI:-2.7,+15.4]; p=0.163). Median age was 24.1 months (IQR:14.0–53.7), peaking during the first four years of life (89/109 cases;81.6%). Primary BSI (46.8%), skin and soft tissue (21.1%), and osteoarticular infections (18.3%) were the most common syndromes. We compared children with primary BSI with those with a known source and observed that the former had shorter hospital stay (7vs.13 days; p=0.003) and received intravenous antibiotics less frequently (72.5%vs.94.8%; p=0.001) and for shorter periods (10vs.21 days; p=0.001). 22% of cases required PICU admission. Factors associated with severity were respiratory distress, pneumonia, thrombocytopenia, and surgery, but in multivariate analysis, only respiratory distress remained significant (adjusted OR:9.23 [95%CI:2.16-29.41]). Two children (1.8%) died. Conclusion: We observed a trend in increased incidence of GAS-BSI within the study period. Younger children were more frequently involved, and primary BSI was the most common and less severe syndrome. PICU admission was frequent, being respiratory distress the main risk factor.